4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Market cap: $177.9M (2/09/2026)
Price: $2.76
Retention Bonuses Approved for CMO Dr. Khurram Jamil and CFO Jack Callicutt
Director Resignation - Marc Rubin Steps Down from Galectin Therapeutics Board
Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit Sufficient to Cover Expected Expenditures Through March 2027
2025 Annual Meeting Results: Directors Elected and Compensation Approved
Announces Exciting Developments Under New Leadership
Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update
Investor Presentation
Annual Report to Security Holders
Q3
Q2
Q1
FY 2024
FY 2023
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Free Writing Prospectus
Prospectus Filed Pursuant to Rule 424(b)(1)